In 2023, Finland exhibited the highest nervous system disease mortality rate among males, while Argentina had the lowest. Notably, countries such as Finland, the United States, and Slovenia saw more substantial year-on-year increases, whereas Spain and Israel experienced declines. Over the past five years, countries like Argentina and Mexico showed minimal annual changes, indicating stability, while Slovenia and Estonia reported higher growth rates, highlighting emerging concerns.
Looking ahead, monitoring trends in healthcare advancements, aging populations, and lifestyle changes will be crucial in understanding and predicting nervous system disease mortality rates globally. These factors could greatly influence future variations among these countries.
Top countries in Nervous System Disease Mortality by Country
| # | 10 Countries | Units (Male Deaths) Per Hundred Thousand Men | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Finland | 158.4 | 2023 | +3.6% | +4.16% | View data |
| 2 | 2 United States | 73.5 | 2023 | +4.55% | +5.44% | View data |
| 3 | 3 United Kingdom | 67.4 | 2023 | +4.5% | +4.96% | View data |
| 4 | 4 Iceland | 66.3 | 2023 | +5.57% | +1.12% | View data |
| 5 | 5 Sweden | 54.5 | 2023 | +2.64% | +2.53% | View data |
| 6 | 6 Denmark | 48.7 | 2023 | +2.96% | +3.1% | View data |
| 7 | 7 Belgium | 48.6 | 2023 | +1.46% | +1.87% | View data |
| 8 | 8 Slovenia | 47.3 | 2023 | +7.01% | +8.06% | View data |
| 9 | 9 Japan | 45.1 | 2023 | +4.88% | +4.44% | View data |
| 10 | 10 Germany | 44.8 | 2023 | +0.9% | +0.82% | View data |
Latest reports
US Autoimmune Disease Market Report- Q1 2025
The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...
China Autoimmune Disease Market Report- Q1 2025
The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...
Japan Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...
Germany Autoimmune Disease Market Report- Q4 2024
The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...
UK Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...
South Korea Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...
